Claim and evidence Close ×
Berg’s news release of 21 November 2013 announces a phase Ib clinical trial at three named centres to study its investigational compound BPM 31510, which it describes as discovered and developed by its Interrogative Biology platform, “an artificial intelligence-based system”. Copy claim link
Copy claim reference
Machine-checked, not reviewed by an editor Stated in source Supported
Supporting evidence: primary · 1 source
Date 2013-11-21 · announcement Records dated 2013 → Role Earliest located Register (kind of text) Nonfiction Scope of the passage A company announcement of a trial, with the company’s account of how the compound was found. Scope and limits The record documents what this text states, in its register; it is not evidence that the proposition is true and implies no influence on or from any other text. The company’s own statement; it is not independent confirmation of how the compound was found or of the trial. An earlier Berg release of 2012 reports clinical development, but its account of discovery by AI was not established, so the wording is not backdated. The research pack had headlined a 2020 release; this one holds the role from the admission (maintainer decision of 2026-10-30). Earliest located for this proposition among the texts found by the searches described under “How we searched”; not a claim that no earlier text exists.
The evidence 02 primary source Supports the claim
Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors ↗ PR Newswire (news release provided by Berg) · 2013-11-21
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “Phase Ib clinical trial with Weill Cornell Medical College, Palo Alto Medical Foundation, and MD Anderson Cancer Center to study its investigational compound, BPM 31510” Location in source Subtitle and opening paragraph
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-31
Source details and check notes Authors Berg Version PR Newswire release page, retrieved directly at admission on 2026-10-31 (SHA-256 e173d855000f3162bf03a5844f2f12dc9d0d99c3dd4ae9fea2c24ae6f5388356); the cross-family check of 2026-10-30 read the same address. The page shows “Nov 21, 2013, 09:29 ET”. Its wording can change; earlier wording is not authenticated. Canonical address Open the canonical source ↗ Accessed 2026-10-31 Language English (en) Attribution Berg, “Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors”, 2013-11-21. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Added at the admission of the AI in biology pack (research/ai-in-biology). Located by the cross-family machine check of 2026-10-30 (item A55 for P2, A56 for P3) and adopted as earliest located by the maintainer’s decision of 2026-10-30. The quotation (25 words) matched a direct retrieval of 2026-10-31 (SHA-256 e173d855000f3162bf03a5844f2f12dc9d0d99c3dd4ae9fea2c24ae6f5388356). Matching ignored differences of whitespace, case, quotation marks and dashes. No human editorial review. primary source Supports the claim
Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors ↗ PR Newswire (news release provided by Berg) · 2013-11-21
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “candidates discovered and developed by the Berg Interrogative Biology TM platform, an artificial intelligence-based system that uses network biology methodologies to study biological systems” Location in source Paragraph on BPM 31510 and the platform
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-31
Source details and check notes Authors Berg Version PR Newswire release page, retrieved directly at admission on 2026-10-31 (SHA-256 e173d855000f3162bf03a5844f2f12dc9d0d99c3dd4ae9fea2c24ae6f5388356); the cross-family check of 2026-10-30 read the same address. The page shows “Nov 21, 2013, 09:29 ET”. Its wording can change; earlier wording is not authenticated. Canonical address Open the canonical source ↗ Accessed 2026-10-31 Language English (en) Attribution Berg, “Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors”, 2013-11-21. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Added at the admission of the AI in biology pack (research/ai-in-biology). Located by the cross-family machine check of 2026-10-30 (item A55 for P2, A56 for P3) and adopted as earliest located by the maintainer’s decision of 2026-10-30. The quotation (24 words) matched a direct retrieval of 2026-10-31 (SHA-256 e173d855000f3162bf03a5844f2f12dc9d0d99c3dd4ae9fea2c24ae6f5388356). Matching ignored differences of whitespace, case, quotation marks and dashes. No human editorial review. Status and meaning Editorial status. Not reviewed by an editor . An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.
Relation. A passage of the document meets the proposition’s criterion. The record documents what the text states, in its register (fiction and satire are labelled); it is not evidence that the proposition is true and implies no influence on or from another text.
Date. Date of the release (“Nov 21, 2013, 09:29 ET”); the announcement date is not the trial’s start date.
Record ID aib-arg-p3-berg-2013